CryoPort, Inc. (CYRX) has returned 81.3% year-to-date, significantly outperforming the Medical sector's 1.6% average return. The company holds a Zacks Rank #2 (Buy) with improving earnings outlook. Delcath Systems, Inc. (DCTH) has also outperformed with a 58.1% year-to-date return and a Zacks Rank #1 (Strong Buy), supported by an 80.7% increase in consensus EPS estimates over three months.

Delcath Systems (DCTH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

The mean of analysts' price targets for Delcath Systems (DCTH) points to a 197.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The mean of analysts' price targets for Delcath Systems (DCTH) points to a 201.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Delcath Systems (DCTH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Wall Street is experiencing a subdued trading session, with all major indices showing minimal movement around midday in New York. The latest producer inflation data provided mixed signals ahead of the highly anticipated consumer inflation report on Wednesday. Fed Chair Jerome Powell reiterated his outlook that U.S. monetary policy will maintain its current rate for a longer period than previously anticipated, dismissing fears of new rate hikes. President Joe Biden announced significant tariffs on Chinese imports, imposing 25% on steel and aluminum, 100% on electric vehicles made in China, 25% on EV batteries, and a 50% tariff on semiconductors from China. The U.S. dollar index (DXY), the Invesco DB USD Index Bullish Fund ETF (NYSE:UUP), fell 0.2% negatively reacting to producer inflation readings and Powell’s remarks. Treasury yields slightly softened, with traders holding expectations of two Fed rate cuts by year-end. All major indices such as the S&P 500, the Dow ...Full story available on Benzinga.com

Steris (STE) delivered earnings and revenue surprises of 0% and 3.07%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

The mean of analysts' price targets for Delcath Systems (DCTH) points to a 244.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 277.7% upside potential for Delcath Systems (DCTH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Delcath Systems (DCTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays cut the price target for Prologis, Inc. (NYSE: PLD) from $153 to $141. Barclays analyst Anthony Powell maintained an Overweight rating. Prologis shares fell 1.6% to close at $125.14 on Tuesday. See how other analysts view this stock. Truist Securities slashed the price target for Berry Global Group, Inc. (NYSE: BERY) from $75 to $68. Truist Securities analyst Michael Roxland downgraded the stock from Buy to Hold. Berry Global shares fell 0.4% to close at $59.23 on Tuesday. See how other analysts view this stock. Wedbush increased Netflix, Inc. (NASDAQ: NFLX) price target from $615 to $725. Wedbush analyst Michael Pachter maintained an Outperform rating. Netflix shares rose 0.3% to close at $629.24 on Tuesday. See how other analysts view this stock. Keefe, Bruyette & Woods boosted the price target ...